P
Podimetrics
Develops an early warning system to predict and prevent diabetic foot ulcers
About Podimetrics
Podimetrics is a healthcare technology startup that operates in the diabetes care market, specifically focusing on preventing diabetic foot complications. The company's primary offering is a clinically-proven technology, the SmartMat™, which is used by patients with advanced diabetes at home. By stepping on the SmartMat™ for just 20 seconds a day, the device can monitor foot temperature over time, alert to early signs of inflammation, and facilitate rapid response to help reduce inflammation before complications start.
Read full description
The company's business model is centered on providing a simple, in-home touchpoint for patients and their healthcare providers. This approach not only empowers patients to manage their foot health and mobility but also helps to curb the spiraling costs associated with diabetic foot complications and amputations.
Podimetrics serves a broad range of clients, including individual patients, healthcare providers, and potentially insurance companies who are interested in reducing the overall cost of diabetes care. The company generates revenue by selling the SmartMat™ device and possibly through a subscription model for ongoing monitoring and support services.
In addition to its technology, Podimetrics differentiates itself through its commitment to human support. The company describes itself as a team of healthcare professionals, technologists, and deeply caring mavericks, dedicated to helping patients maintain their mobility and quality of life.
At a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Somerville, United States
- Employees
- 125
- Open positions
- None listed
- Dealroom signal
- 63.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Oncology, Surgery, Patient Care, Core AI, Spinout, Clinical Decision Support
- Business model
- Marketplace & ecommerce
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Nov 2022 | $25M | — | CIBC Innovation Banking | ↗ |
| SERIES COther financing | Mar 2022 | $45M | $180M | Polaris Partners · D1 Capital Partners · Scientific Health Development Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Podimetrics is 9.1K monthly website visits, up 12.3% over the last three months. Podimetrics's team declined 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Norwich Ventures
Rock Health
Series A2 investors entered at this stage
Polaris Partners
Scientific Health Development Partners
Series B and later2 investors entered at this stage
D1 Capital Partners
CIBC Innovation Banking
Other known investors1 additional known investor
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Podimetrics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Podimetrics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.